SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Designed for symptomatic individuals within six days of symptom onset, the QuickVue COVID-19 test is cleared for use in individuals aged 14 or older when self-testing, and in those aged two and older ...
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho (QDEL)"), a leading global provider of ...
Select independently determines what we cover and recommend. When you buy through our links, we may earn a commission. Learn more. Gone are the days of visiting a doctor’s office to determine whether ...
Imagine waking up, brushing your teeth, and quickly swabbing your nose to test for the coronavirus — whether you feel sick or not. That reality just got a bit closer with an announcement from the Food ...
WASHINGTON - The U.S. Food and Drug Administration has granted emergency use authorization for another COVID-19 at-home test. The agency approved the Quidel QuickVue At-Home COVID-19 Test, allowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results